Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ mice.
Abecassis
M
M
Toronto General Hospital, Ontario, Canada.
Falk
J
J
Dindzans
V
V
Lopatin
W
W
Makowka
L
L
Levy
G
G
Falk
R
R
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000818:Animals; D001779:Blood Coagulation Factors / Q000096:biosynthesis; D003588:Cytopathogenic Effect, Viral; D006524:Hepatitis, Viral, Animal / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D066298:In Vitro Techniques; D008264:Macrophages / Q000201:enzymology / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D006517:Murine hepatitis virus; D011459:Prostaglandins E, Synthetic / Q000494:pharmacology*
D001779:Blood Coagulation Factors; D011459:Prostaglandins E, Synthetic; C045072:macrophage procoagulant activity; D015064:16,16-Dimethylprostaglandin E2